Seattle-area families living with ALS got a rare taste of stadium life this month, as the Rose Watkins ALS Tour of Dreams brought its traveling VIP experience to Lumen Field. The nonprofit's visit offered local patients behind-the-scenes access to the home of the Seahawks and Sounders FC, part of a growing national effort to give people facing the terminal disease a day they won't forget.
The tour was founded in memory of Rose Watkins, a passionate Kansas City Chiefs fan who lived with ALS for six years before her death in 2023, according to FOX 13 Seattle. Her son, Amecco Watkins, established the organization just over a year before the Seattle visit, and he now serves as its founder and CEO. The idea for the tour itself was inspired by two Kansas City Chiefs superfans, and the program aims to offer memorable experiences for people confronting a disease that offers little room for delay.
“Als patients are not guaranteed tomorrow or the year after that,” Watkins told the station, describing the urgency behind the mission. He said the goal is simple: get each patient out of the house and into a stadium for a VIP tour, giving them a day built around the sport or team they love.
A Fast-Growing National Tour
The Rose Watkins ALS Tour of Dreams held its first VIP stadium experience at Arrowhead Stadium in Kansas City on August 13, 2025, granting dream tour moments to Chiefs superfans Rachel Beason and Chad Branson, according to the organization's own account on its website. Just days before the Seattle stop, the tour expanded to Lambeau Field in Green Bay, Wisconsin, on August 18, hosting more than 20 ALS patients, caregivers, and family members for a VIP stadium and Packers Hall of Fame tour that included player meet-and-greets after practice, per a report from WLUK-TV.
The tour is not slowing down. It's scheduled to visit Nissan Stadium in Nashville and Highmark Stadium in Buffalo later this season, continuing to connect fans living with ALS to behind-the-scenes stadium access across the country as it travels to professional sports venues nationwide.
Why Lumen Field Works for This Mission
Lumen Field's own accessibility features made it a natural stop for patients with severe mobility limitations. The venue offers four corner ADA-compliant entry ramps, dedicated wheelchair escort services, and accessible seating across all concourses, along with a policy granting complimentary admission to personal care attendants accompanying disabled fans, according to the Seattle Seahawks.
That kind of infrastructure matters given how fast ALS can progress. The ALS Association estimates roughly 5,000 Americans are diagnosed each year — about 15 new cases a day — with an average post-diagnosis life expectancy of just two to five years, though some 20% of patients live longer, per ALS News Today. A Centers for Disease Control and Prevention study published in January 2025 projected U.S. ALS cases would climb from nearly 33,000 in 2022 to more than 36,000 by 2030, an increase of over 10%.
Financial Backing Grows Alongside the Tour
The organization recently picked up its first official corporate sponsor. Morris Smith Ford announced in September 2026 that it would provide financial support as the nonprofit expands its stadium schedule, a move that helps offset the travel and logistical costs families face when joining a tour stop.
The tour also operates within a broader network of ALS advocacy groups. Team Gleason, founded in 2011 by former Washington State University and NFL player Steve Gleason after his own ALS diagnosis, has provided more than $65 million in equipment, technology, and adventure travel funding for ALS patients, including help covering costs for stadium tour participants.
Medical Advances Offer Hope for Some Patients
While the Tour of Dreams focuses on quality of life, researchers continue chasing treatments that could slow the disease itself. Long-term results published in JAMA Neurology in May showed that early use of the gene-silencing drug tofersen led to functional stabilization or partial improvement in about 25% of trial participants with the SOD1-mutation form of ALS, a finding Hoodline covered in its report on a St. Louis-linked ALS drug turnaround. Those gains apply only to a specific genetic subtype, and ALS remains a rapidly progressive, terminal condition for the vast majority of the roughly 33,000 Americans living with it.
For now, the Rose Watkins ALS Tour of Dreams is focused on what it can control: getting patients through stadium gates while there's still time. As the tour heads next to Nashville and Buffalo, organizers say the mission remains the same one that started it all in Kansas City — turning a fan's love of the game into a lasting memory.
